• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

二尖瓣关闭不全超声心动图评分:犬黏液瘤性二尖瓣疾病的严重程度分级。

The Mitral INsufficiency Echocardiographic score: A severity classification of myxomatous mitral valve disease in dogs.

机构信息

Department of Veterinary Sciences, University of Pisa, Pisa, Italy.

Department of Cardiology, Anicura Istituto Veterinario Novara, Granozzo con Monticello, Italy.

出版信息

J Vet Intern Med. 2021 May;35(3):1238-1244. doi: 10.1111/jvim.16131. Epub 2021 May 5.

DOI:10.1111/jvim.16131
PMID:33951235
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8163114/
Abstract

BACKGROUND

There is no commonly shared severity score for myxomatous mitral valve disease (MMVD) based on routinely acquired echocardiographic variables.

HYPOTHESIS/OBJECTIVES: To propose an easy-to-use echocardiographic classification of severity of MMVD in dogs.

ANIMALS

Five hundred and sixty dogs with MMVD.

METHODS

This was a retrospective, multicenter, observational study. The proposed Mitral INsufficiency Echocardiographic (MINE) score was based on 4 echocardiographic variables: left atrium-to-aorta ratio, left ventricular end-diastolic diameter normalized for body weight, fractional shortening, and E-wave transmitral peak velocity. Specific echocardiographic cutoffs were defined based on previous prognostic studies on MMVD, and severity scores were assigned as follows: mild (score: 4-5), moderate (score: 6-7), severe (score: 8-12), late stage (score: 13-14).

RESULTS

Median survival time was significantly different (P < .05) between the proposed severity classes: mild (2344 days, 95% confidence interval [CI] 1877-2810 days), moderate (1882 days, 95% CI 1341-2434 days), severe (623 days, 95% CI 432-710 days), and late stage (157 days, 95% CI 53-257 days). A MINE score >8 was predictive of cardiac death (area under the curve = 0.85; P < .0001; sensitivity 87%, specificity 73%). In the multivariable analysis, all the echocardiographic variables of the MINE score were independent predictors of death because of heart disease (P < .001).

CONCLUSIONS AND CLINICAL IMPORTANCE

The MINE score is a new easy-to-use echocardiographic classification of severity of MMVD, which has been proven to be clinically effective as it is associated with survival. This classification provides prognostic information and could be useful for an objective echocardiographic assessment of MMVD.

摘要

背景

目前尚无基于常规获取的超声心动图变量的普遍共识的黏液样心肌二尖瓣疾病(MMVD)严重程度评分。

假设/目的:提出一种易于使用的 MMVD 严重程度的超声心动图分类方法。

动物

560 只患有 MMVD 的狗。

方法

这是一项回顾性、多中心、观察性研究。提出的二尖瓣反流超声心动图(MINE)评分基于 4 个超声心动图变量:左心房与主动脉比值、左心室舒张末期直径按体重标准化、分数缩短和 E 波经二尖瓣峰值速度。具体的超声心动图截止值基于先前关于 MMVD 的预后研究确定,并分配严重程度评分如下:轻度(评分:4-5)、中度(评分:6-7)、重度(评分:8-12)、晚期(评分:13-14)。

结果

中位生存时间在提出的严重程度类别之间有显著差异(P <.05):轻度(2344 天,95%置信区间 [CI] 1877-2810 天)、中度(1882 天,95% CI 1341-2434 天)、重度(623 天,95% CI 432-710 天)和晚期(157 天,95% CI 53-257 天)。MINE 评分 >8 预测心脏死亡(曲线下面积 = 0.85;P <.0001;敏感性 87%,特异性 73%)。在多变量分析中,MINE 评分的所有超声心动图变量都是心脏病死亡的独立预测因素(P <.001)。

结论和临床意义

MINE 评分是一种新的易于使用的 MMVD 严重程度的超声心动图分类方法,已被证明具有临床有效性,因为它与生存相关。这种分类提供了预后信息,可用于 MMVD 的客观超声心动图评估。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2c3/8163114/c277e72b41e1/JVIM-35-1238-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2c3/8163114/7aa2a660ed18/JVIM-35-1238-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2c3/8163114/434e0ebe7f70/JVIM-35-1238-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2c3/8163114/c277e72b41e1/JVIM-35-1238-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2c3/8163114/7aa2a660ed18/JVIM-35-1238-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2c3/8163114/434e0ebe7f70/JVIM-35-1238-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2c3/8163114/c277e72b41e1/JVIM-35-1238-g002.jpg

相似文献

1
The Mitral INsufficiency Echocardiographic score: A severity classification of myxomatous mitral valve disease in dogs.二尖瓣关闭不全超声心动图评分:犬黏液瘤性二尖瓣疾病的严重程度分级。
J Vet Intern Med. 2021 May;35(3):1238-1244. doi: 10.1111/jvim.16131. Epub 2021 May 5.
2
Echocardiographic parameters for the assessment of congestive heart failure in dogs with myxomatous mitral valve disease and moderate to severe mitral regurgitation.超声心动图参数用于评估患有黏液样二尖瓣疾病和中重度二尖瓣反流的充血性心力衰竭犬。
Vet J. 2020 Sep;263:105518. doi: 10.1016/j.tvjl.2020.105518. Epub 2020 Jul 18.
3
Efficacy of a mitral regurgitation severity index to predict long-term outcome in dogs with myxomatous mitral valve disease.二尖瓣反流严重指数对黏液样变性性二尖瓣疾病犬长期预后的预测效果。
J Vet Intern Med. 2024 Jan-Feb;38(1):51-60. doi: 10.1111/jvim.16923. Epub 2023 Nov 1.
4
Echocardiographic predictors of survival in dogs with myxomatous mitral valve disease.黏液瘤样二尖瓣疾病犬生存的超声心动图预测指标
J Vet Cardiol. 2015 Mar;17(1):1-12. doi: 10.1016/j.jvc.2014.11.001. Epub 2015 Jan 10.
5
Anatomic regurgitant orifice area obtained using 3D-echocardiography as an indicator of severity of mitral regurgitation in dogs with myxomatous mitral valve disease.使用三维超声心动图获得的解剖反流口面积作为黏液瘤性二尖瓣疾病犬二尖瓣反流严重程度的指标。
J Vet Cardiol. 2017 Oct;19(5):433-440. doi: 10.1016/j.jvc.2017.07.001. Epub 2017 Sep 28.
6
Prognostic value of selected one-, two- and three-dimensional and Doppler echocardiographic methods to assess severity in dogs with myxomatous mitral valve disease.选择的一维、二维和三维及多普勒超声心动图方法对黏液瘤性二尖瓣疾病犬严重程度评估的预后价值。
J Vet Cardiol. 2022 Feb;39:89-101. doi: 10.1016/j.jvc.2021.12.005. Epub 2021 Dec 9.
7
Prognostic value of echocardiographic indices of left atrial morphology and function in dogs with myxomatous mitral valve disease.黏液瘤样二尖瓣疾病犬左心房形态和功能超声心动图指标的预后价值
J Vet Intern Med. 2018 May;32(3):914-921. doi: 10.1111/jvim.15093. Epub 2018 Mar 23.
8
Prognostic value of left atrial stiffness estimated using echocardiography in dogs with myxomatous mitral valve disease.超声心动图评估左心房僵硬度对黏液瘤样二尖瓣病犬的预后价值。
J Vet Cardiol. 2023 Feb;45:15-26. doi: 10.1016/j.jvc.2022.12.001. Epub 2022 Dec 6.
9
The predictive value of clinical, radiographic, echocardiographic variables and cardiac biomarkers for assessing risk of the onset of heart failure or cardiac death in dogs with preclinical myxomatous mitral valve disease enrolled in the DELAY study.在DELAY研究中,临床、影像学、超声心动图变量及心脏生物标志物对评估患有临床前期黏液瘤性二尖瓣疾病的犬发生心力衰竭或心源性死亡风险的预测价值。
J Vet Cardiol. 2021 Aug;36:77-88. doi: 10.1016/j.jvc.2021.04.009. Epub 2021 May 16.
10
Utility of focused cardiac ultrasonography training in veterinary students to differentiate stages of subclinical myxomatous mitral valve disease in dogs.超声心动图在兽医学生中对犬亚临床黏液瘤性二尖瓣疾病分期的应用。
J Vet Intern Med. 2024 May-Jun;38(3):1325-1333. doi: 10.1111/jvim.17056. Epub 2024 Mar 27.

引用本文的文献

1
Risk Stratification Using Mitral INsufficiency Echocardiographic Score 2 in Dogs With Preclinical Mitral Valve Disease.使用二尖瓣反流超声心动图评分2对患有临床前期二尖瓣疾病的犬进行风险分层。
J Vet Intern Med. 2025 Sep-Oct;39(5):e70215. doi: 10.1111/jvim.70215.
2
A Novel Echocardiographic Index (Modified-Left-Atrium-to-Aorta Ratio) for Quantifying Left Atrial Size and Differentiating Stages in Dogs with Myxomatous Mitral Valve Disease.一种用于量化患有黏液瘤性二尖瓣疾病犬的左心房大小和区分疾病阶段的新型超声心动图指数(改良左心房与主动脉比值)
Animals (Basel). 2025 Jun 19;15(12):1820. doi: 10.3390/ani15121820.
3
Deep learning-based evaluation of the severity of mitral regurgitation in canine myxomatous mitral valve disease patients using digital stethoscope recordings.

本文引用的文献

1
DELay of Appearance of sYmptoms of Canine Degenerative Mitral Valve Disease Treated with Spironolactone and Benazepril: the DELAY Study.螺内酯和贝那普利治疗犬退行性二尖瓣疾病症状出现的延迟:DELAY研究
J Vet Cardiol. 2020 Feb;27:34-53. doi: 10.1016/j.jvc.2019.12.002. Epub 2020 Jan 10.
2
Echocardiographic quantitation of left heart size and function in 122 healthy dogs: A prospective study proposing reference intervals and assessing repeatability.122 只健康犬左心大小和功能的超声心动图定量:一项提出参考范围并评估重复性的前瞻性研究。
J Vet Intern Med. 2019 Sep;33(5):1909-1920. doi: 10.1111/jvim.15562. Epub 2019 Jul 16.
3
基于深度学习,利用数字听诊器记录评估犬黏液瘤性二尖瓣疾病患者二尖瓣反流的严重程度
BMC Vet Res. 2025 May 8;21(1):326. doi: 10.1186/s12917-025-04802-z.
4
Vertebral Heart Score and Vertebral Left Atrial Size as Radiographic Measurements for Cardiac Size in Dogs-A Literature Review.犬心脏大小的影像学测量指标——椎体心脏评分和椎体左心房大小:文献综述
Animals (Basel). 2025 Feb 26;15(5):683. doi: 10.3390/ani15050683.
5
Comparison Between Radiographic Vertebral Left Atrial Size (VLAS) and Echocardiographic Methods for Predicting Left Atrial Remodeling in Dogs With Mitral Valve Disease.用于预测二尖瓣疾病犬左心房重构的X线片测量的椎体左心房大小(VLAS)与超声心动图方法的比较
Vet Med Int. 2025 Feb 6;2025:5516116. doi: 10.1155/vmi/5516116. eCollection 2025.
6
Assessing the use of blood microRNA expression patterns for predictive diagnosis of myxomatous mitral valve disease in dogs.评估血液中微小RNA表达模式用于犬黏液瘤样二尖瓣疾病预测诊断的应用。
Front Vet Sci. 2024 Nov 1;11:1443847. doi: 10.3389/fvets.2024.1443847. eCollection 2024.
7
Radiographic and echocardiographic evaluation in rescued Korean raccoon dogs ().对获救的韩国貉进行的影像学和超声心动图评估()。
Front Vet Sci. 2024 Jun 28;11:1361843. doi: 10.3389/fvets.2024.1361843. eCollection 2024.
8
RNA sequencing provides novel insights into the pathogenesis of naturally occurring myxomatous mitral valve disease stage B1 in beagle dogs.RNA 测序为研究比格犬自然发生的黏液样二尖瓣病变 B1 期的发病机制提供了新的见解。
PLoS One. 2024 May 16;19(5):e0300813. doi: 10.1371/journal.pone.0300813. eCollection 2024.
9
Myxomatous Mitral Valve Disease in Large Breed Dogs: Survival Characteristics and Prognostic Variables.大型犬黏液瘤性二尖瓣疾病:生存特征与预后变量
Vet Sci. 2024 Mar 21;11(3):136. doi: 10.3390/vetsci11030136.
10
Machine Learning Techniques for Canine Myxomatous Mitral Valve Disease Classification: Integrating Anamnesis, Quality of Life Survey, and Physical Examination.用于犬黏液瘤性二尖瓣疾病分类的机器学习技术:整合病历、生活质量调查和体格检查
Vet Sci. 2024 Mar 6;11(3):118. doi: 10.3390/vetsci11030118.
ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs.
ACVIM 共识指南:犬黏液瘤性二尖瓣疾病的诊断与治疗。
J Vet Intern Med. 2019 May;33(3):1127-1140. doi: 10.1111/jvim.15488. Epub 2019 Apr 11.
4
Echocardiographic indices and severity of mitral regurgitation in dogs with preclinical degenerative mitral valve disease.患有临床前期退行性二尖瓣疾病犬的超声心动图指标与二尖瓣反流严重程度
J Vet Intern Med. 2019 Mar;33(2):489-498. doi: 10.1111/jvim.15461. Epub 2019 Feb 22.
5
ACVIM consensus statement: Guidelines for the identification, evaluation, and management of systemic hypertension in dogs and cats.美国兽医内科学会共识声明:犬猫系统性高血压的识别、评估及管理指南
J Vet Intern Med. 2018 Nov;32(6):1803-1822. doi: 10.1111/jvim.15331. Epub 2018 Oct 24.
6
Anatomic regurgitant orifice area obtained using 3D-echocardiography as an indicator of severity of mitral regurgitation in dogs with myxomatous mitral valve disease.使用三维超声心动图获得的解剖反流口面积作为黏液瘤性二尖瓣疾病犬二尖瓣反流严重程度的指标。
J Vet Cardiol. 2017 Oct;19(5):433-440. doi: 10.1016/j.jvc.2017.07.001. Epub 2017 Sep 28.
7
Mitral Regurgitation Severity and Left Ventricular Systolic Dimension Predict Survival in Young Cavalier King Charles Spaniels.二尖瓣反流严重程度和左心室收缩维度可预测年轻查理士王小猎犬的生存率。
J Vet Intern Med. 2017 Jul;31(4):1008-1016. doi: 10.1111/jvim.14759. Epub 2017 Jun 1.
8
Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation: A Report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance.原发性瓣膜反流的非侵入性评估建议:美国超声心动图学会与心血管磁共振学会合作制定的报告
J Am Soc Echocardiogr. 2017 Apr;30(4):303-371. doi: 10.1016/j.echo.2017.01.007. Epub 2017 Mar 14.
9
Real-Time 3-Dimensional Echocardiographic Assessment of Effective Regurgitant Orifice Area in Dogs With Myxomatous Mitral Valve Disease.实时三维超声心动图评估黏液瘤样二尖瓣疾病犬的有效反流口面积
J Vet Intern Med. 2017 Mar;31(2):303-310. doi: 10.1111/jvim.14642. Epub 2017 Jan 21.
10
Effect of Pimobendan in Dogs with Preclinical Myxomatous Mitral Valve Disease and Cardiomegaly: The EPIC Study-A Randomized Clinical Trial.匹莫苯丹对患有临床前期黏液瘤性二尖瓣疾病和心脏肥大犬的影响:EPIC研究——一项随机临床试验。
J Vet Intern Med. 2016 Nov;30(6):1765-1779. doi: 10.1111/jvim.14586. Epub 2016 Sep 28.